Dr Srimathy Vijayan MRes, MRCP (London), FRACP

Consultant Neurologist, Movement Disorders Clinic

Dr Srimathy Vijayan is a consultant neurologist in the Perron Institute for Neurological and Translational Science clinic.

Her key interest is movement disorders including the management of complex Parkinson’s Disease and advanced therapies, particularly that of deep brain stimulation (DBS) and programming. She also performs botulinum toxin (botox) injection for both movement disorders including dystonia, hemifacial spasm and blepharospasm and spasticity.

Dr Vijayan works alongside the clinical team at the Perron Institute including Clinic Manager Sue Walters, Parkinson’s nurse Alexa Jefferson and MS nurse Denise Menzies to provide specialist DBS programming and botox clinics.

Dr Vijayan graduated from University of East Anglia Norwich UK in 2009. She completed junior medical training in London before pursuing her medical training at the prestigious John Radcliffe Hospital in Oxford. She obtained her Member of Royal College of Physicians (MRCP) London before moving to Australia in 2013. She trained in neurology at the three tertiary hospitals in the Perth area, Sir Charles Gairdner Hospital (SCGH), Royal Perth Hospital and Fiona Stanley Hospital, and was awarded Fellowship of the Royal Australasian College of Physicians (FRACP) in 2019.

As well as her clinical work, Dr Vijayan has a keen interest in teaching and training of undergraduate medical students at The University of Western Australia. Furthermore, she is currently undertaking a PhD with the University of Western Australia and the Perron Institute in an unmet area of movement disorders which she is passionate about. Her research interest stems from her undergraduate studies where she also obtained a Masters in Health Research (MRes) with distinction.

Her PhD is evaluating the effect of deep brain stimulation (DBS) on sleep and breathing function in Parkinson’s. She is actively recruiting for this study at present, named PEDS – PD – a “Pilot study evaluating the Effects of Deep brain stimulation on Sleep and pulmonary function in Parkinson’s Disease”. Patients with a diagnosis of Parkinson’s are being invited to take part in the prospective study conducted at the sleep / pulmonary department at SCGH. Patients are required to visit on at least two occasions to undergo an overnight sleep study with the DBS ON and then OFF. Those taking part in the pulmonary tests will be required to attend on four separate occasions for specialised breathing tests including spirometry and control of ventilation studies with the DBS machine ON and then turned OFF. She is also undertaking the specialised breathing tests in medically treated Parkinson’s patients and is actively seeking participants for this component of the study too. This study would not be possible without the support of her mentors/supervisors who are: Associate Professor Rick Stell, Professor Frank Mastaglia and Clinical Professor Bhajan Singh, Professor Norman Palmer, Professor Jennifer Rodger and Clinical Professor Graeme Hankey to whom she is grateful.

Dr Vijayan continues her clinical work alongside her research to ultimately improve the care and wellbeing of patients with these disorders.